With over 22+ years experience in clinical drug development, Angela Fleming is a Director of Clinical Affairs at MCRA. Ms. Fleming specializes in oversight of clinical trials in a vast array of therapeutic areas with extensive knowledge of planning, executing, and monitoring clinical trials. Ms. Fleming fosters a mentoring approach with team members and has well established trust among site teams and sponsors. Ms. Fleming's work at MCRA focuses primarily on novel technologies and therapeutics for which clinical data is necessary.
Ms. Fleming attended both The College at Brockport State University of New York, as well as the University of Maryland.
Prior to joining MCRA in October 2018, Ms. Fleming has worked in all phases of Phase I, II, III, and IV clinical trials in Biotech, Pharmaceutical, and CRO/Sponsor environments.
Overview
Ms. Fleming's work at MCRA focuses primarily on novel technologies and therapeutics for which clinical data is necessary.